Patents by Inventor Annika Bjore

Annika Bjore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20060166980
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 27, 2006
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffmann, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • Bispidine compounds useful in the treatment of cardiac arrythmias
    Publication number: 20040229900
    Abstract: There is provided compounds of formula I, 1
    Type: Application
    Filed: June 21, 2004
    Publication date: November 18, 2004
    Applicant: AstraZeneca AB
    Inventors: Christer Alstermark, Kjell Andersson, Annika Bjore, Magnus Bjorsne, Eva-Lotte Lindstedt Alstermark, Goran N. Nilsson, Magnus Polla, Gert Strandlund, Yiva Ortengren
  • New bispidine compounds and their use in the treatment of cardiac arrhythmias
    Publication number: 20030212095
    Abstract: There is provided compounds of formula (I), wherein R1, R2, R3a, R3b and R41 to R46 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: May 14, 2003
    Publication date: November 13, 2003
    Inventors: Kjell Andersson, Annika Bjore, Magnus Bjorsne, Fritiof Ponten, Gert Strandlund, Peder Svensson, Louise Tottie
  • New oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20030153564
    Abstract: There is provided compounds of formula I, 1
    Type: Application
    Filed: December 12, 2002
    Publication date: August 14, 2003
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffmann, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • Oxabispidine compounds useful in the treatment of cardiac arrhyythmias
    Patent number: 6559143
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: October 16, 2000
    Date of Patent: May 6, 2003
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, Kurt-Jürgen Hoffmann, Fritiof Pontén, Gert Strandlund, Peder Svensson, Michael Wilsterman
  • Dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound
    Patent number: 6492382
    Abstract: The present invention relates to dried preparations containing a class III antiarrhythmic compound in the form of a crystalline or amorphous salt or any combination thereof, where the counterion is selected from pharmaceutically acceptable water-soluble organic or inorganic acids. The present invention also relates to frozen preparations containing a class III antiarrhythmic compound in the form of a salt solution, where the counterion is selected from pharmaceutically acceptable water-soluble organic or inorganic acids. Preferred preparations contain a salt of the compound 3,7-diazabicyclo[3.3.1]-nonane-3-carboxylic acid, 7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-1,1-dimethylethyl ester (Compound A). Further aspects of the present invention include salts of Compound A per se, processes for preparing the preparations, as well as use of the preparations for prophylaxis and/or treatment of cardiac arrhytmia.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: December 10, 2002
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Anna-Karin Granath
  • Bispidine antiarrhythmic compounds
    Patent number: 6291475
    Abstract: There is provided a compound of formula I, wherein R1, R2, R9, R10, R11, R12, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: September 18, 2001
    Assignee: AstraZeneca AB
    Inventors: Christer Alstermark, Annika Björe, Magnus Björsne, Marianne Frantsi, Torbjörn Halvarsson, Kurt-Jürgen Hoffmann, Eva-Lotte Lindstedt, Magnus Polla, Gert Strandlund